Credit Suisse & AstraZeneca Features As BofA-ML’s Analysts’ Top Picks For 2017’s First Quarter
‘Consensus estimates are far too bearish for 2017’, said the experienced analysts of BofA- ML.
BofA-ML
‘Consensus estimates are far too bearish for 2017’, said the experienced analysts of BofA- ML.
